Pdl Biopharma Inc (PDLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 1,602 | 110,701 | 88,365 | 67,633 | 7,194 |
| Depreciation Amortization | 9,429 | 38,093 | 28,111 | 18,149 | 8,756 |
| Income taxes - deferred | 794 | 39,172 | 28,970 | 29,223 | 15,321 |
| Accounts receivable | 8,492 | 9,608 | 23,165 | 15,058 | 18,441 |
| Accounts payable and accrued liabilities | -9,940 | 10,840 | 1,395 | 993 | 10,932 |
| Other Working Capital | -13,879 | 20,866 | 42,500 | 38,768 | 25,135 |
| Other Operating Activity | -10,019 | -188,656 | -154,443 | -108,212 | -39,997 |
| Operating Cash Flow | $-13,521 | $40,624 | $58,063 | $61,612 | $45,782 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | 75,000 | N/A | N/A | N/A |
| PPE Investments | -1,398 | -1,297 | -1,160 | -705 | 7,356 |
| Purchase Of Investment | N/A | -23,213 | -23,213 | -19,860 | -15,975 |
| Sale Of Investment | 4,115 | 39,956 | 112,895 | 29,045 | 16,015 |
| Purchase Sale Intangibles | N/A | 107,253 | 74,404 | 48,062 | 13,494 |
| Other Investing Activity | 18,623 | 368,441 | 335,544 | 164,373 | 121,663 |
| Investing Cash Flow | $21,340 | $458,887 | $424,066 | $172,853 | $129,059 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -126,447 | N/A | N/A | N/A | N/A |
| Common Stock Repurchased | -3,560 | -30,000 | -30,000 | -30,000 | -7,647 |
| Dividend Paid | N/A | -222 | -21 | -21 | -21 |
| Other Financing Activity | 0 | -89,177 | -89,177 | -2,170 | 0 |
| Financing Cash Flow | $-130,007 | $-119,399 | $-119,198 | $-32,191 | $-7,668 |
| Beginning Cash Position | 527,266 | 147,154 | 147,154 | 147,154 | 147,154 |
| End Cash Position | 405,078 | 527,266 | 510,085 | 349,428 | 314,327 |
| Net Cash Flow | $-122,188 | $380,112 | $362,931 | $202,274 | $167,173 |
| Free Cash Flow | |||||
| Operating Cash Flow | -13,521 | 40,624 | 58,063 | 61,612 | 45,782 |
| Capital Expenditure | -1,398 | -1,297 | -1,160 | -705 | -534 |
| Free Cash Flow | -14,919 | 39,327 | 56,903 | 60,907 | 45,248 |